12 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
23678871	59	Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes.	Glaxosmithkline
9458785	10	Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.	Wake Forest University
12475240	2	Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor.	Ucla And The Wadsworth Veterans Administration Hospital
16134951	67	Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).	Pfizer
16134950	45	Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).	Pharmacia
20504026	35	Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter.	University Of Maryland
15582416	20	Synthesis and biological evaluation of novel steroidal pyrazoles as substrates for bile acid transporters.	Xenoport
14980661	6	A novel class of apical sodium-dependent bile acid transporter inhibitors: the amphiphilic 4-oxo-1-phenyl-1,4-dihydroquinoline derivatives.	Sankyo
14552767	22	A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 1,2-benzothiazepines.	Pfizer
10698453	8	A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 2,3-disubstituted-4-phenylquinolines.	Searle Discovery
17149856	8	Discovery of oxadiazoyl tertiary carbinamine inhibitors of beta-secretase (BACE-1).	Merck Research Laboratories